<DOC>
	<DOCNO>NCT00324922</DOCNO>
	<brief_summary>The primary question study understand trimethoprim-sulfamethoxazole ( TMP-SMX ) effective vancomycin treat methicillin-resistant Staphylococcus aureus ( MRSA ) osteomyelitis .</brief_summary>
	<brief_title>Vancomycin Or Trimethoprim/Sulfamethoxazole Methicillin-resistant Staphylococcus Aureus ( MRSA ) Osteomyelitis ( VOTSMO )</brief_title>
	<detailed_description>Treatment osteomyelitis hamper paucity evidence prospective clinical trial randomize treatment arm . Furthermore , previous randomize observational trial enrol small number subject thus often non-definitive finding . One common cause osteomyelitis Staphylococcus aureus . Over past 10 year , rate methicillin-resistant S. aureus ( MRSA ) rise dramatically . Vancomycin currently treatment choice treat MRSA . While vancomycin effective , available intravenous formulation renal bone marrow toxicity . There critical need effective , oral , cheap drug treatment MRSA . Trimethoprim-sulfamethoxazole ( TMP-SMX ) drug several advantageous property treatment MRSA osteomyelitis . To address question regard optimal treatment MRSA osteomyelitis , design prospective , randomized trial compare TMP-SMX vancomycin treatment MRSA osteomyelitis .</detailed_description>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Osteomyelitis</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>1 . Cultureproven MRSA , obtain operating room sterile biopsy procedure bone site . The infection sample site either within bone deep softtissue site contiguous bone ; OR radiographic abnormality consistent osteomyelitis conjunction positive blood culture MRSA . 2 . Surgical debridement infection site , need . 3 . Subject capable provide write informed consent . 4 . Subject least 18 year age . 5 . Subject capable receiving outpatient parenteral therapy 12 week . 1 . Hypersensitivity TMPSMX vancomycin . 2 . S. aureus resistant TMPSMX vancomycin . 3 . Osteomyelitis develop directly chronic , open wound . 4 . Polymicrobial culture ( exception coagulasenegative staphylococcus present culture clinical assessment contaminant ) . 5 . Subject positive pregnancy test study enrollment . 6 . Convicted felon currently prison . 7 . Baseline renal hepatic insufficiency would preclude administration study drug . 8 . Active injection drug use without safe condition administer intravenous antibiotic 3 month . 9 . Anticipated use antibiotic great 14 day infection osteomyelitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Vancomycin</keyword>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
</DOC>